Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters








Database
Language
Publication year range
1.
Int J Oral Maxillofac Surg ; 47(6): 794-801, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29307502

ABSTRACT

Little research has been conducted into hypoesthesia, and no studies have elucidated the risk factors for refractory hypoesthesia and compared treatment modalities. The purpose of this multicentre retrospective cohort study was to investigate the relationships between various risk factors, treatment modalities, and refractory hypoesthesia. Risk factors for refractory hypoesthesia after oral surgery were evaluated using univariate and multivariate analysis. To minimize the selection bias associated with a retrospective data analysis, a propensity score analysis was performed between the medication and non-medication groups (65 sites in each group). Moderate or severe hypoesthesia (odds ratio 13.42) and no or late administration of ATP/vitamin B12 (odds ratio 2.28) were significantly associated with refractory hypoesthesia. In the propensity score analysis, the incidence rate of refractory hypoesthesia in the medication group was lower than that in the non-medication group (P<0.001). This study demonstrated the multivariate relationships between various risk factors, treatment modalities, and refractory hypoesthesia. Moderate or severe hypoesthesia and no or late administration of ATP/vitamin B12 were significantly associated with refractory hypoesthesia. Therefore, clinicians should consider these risk factors and initiate early oral administration of ATP/vitamin B12 in cases of hypoesthesia.


Subject(s)
Hypesthesia/etiology , Oral Surgical Procedures , Postoperative Complications/etiology , Trigeminal Nerve Injuries/etiology , Adenosine Triphosphate/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Hypesthesia/diagnostic imaging , Hypesthesia/drug therapy , Male , Mandibular Nerve , Middle Aged , Postoperative Complications/diagnostic imaging , Postoperative Complications/drug therapy , Propensity Score , Retrospective Studies , Risk Factors , Treatment Outcome , Trigeminal Nerve Injuries/diagnostic imaging , Trigeminal Nerve Injuries/drug therapy , Vitamin B 12/therapeutic use
2.
Int J Oral Maxillofac Surg ; 44(10): 1225-30, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26119366

ABSTRACT

Parenteral antibiotic prophylaxis is the current standard of therapy in clean-contaminated oral cancer surgery. Nevertheless, the incidence of surgical site infection (SSI) in oral oncological surgery is relatively high, especially in major surgery with reconstruction and tracheotomy. The aims of this study were to investigate the perioperative condition related to microorganisms in the oral cavity and to examine the efficacy of the topical administration of tetracycline in reducing the number of bacteria in the oropharyngeal fluid during intubation. The number of oral bacteria was measured during intubation in patients undergoing major oral cancer surgery. The efficacy of the topical administration of tetracycline or povidone iodine gel in reducing the bacteria was then investigated. Bacteria in the oropharyngeal fluid grew from 10(6)CFU/ml to 10(8)CFU/ml during the 3h after intubation (CFU, colony-forming units). When tetracycline was applied to the dorsum of the tongue, oral bacteria decreased immediately to 10(5)CFU/ml, and the number of bacteria in the oropharyngeal fluid was maintained below 10(7)CFU/ml for 7h. The concentration of tetracycline in the oropharyngeal fluid was extremely high for several hours after topical administration. The topical administration of tetracycline could reduce oral bacteria in patients undergoing clean-contaminated oral cancer surgery. This method is expected to be effective in the prevention of SSI.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Antibiotic Prophylaxis , Mouth Neoplasms/surgery , Pharmaceutic Aids/administration & dosage , Povidone/administration & dosage , Surgical Wound Infection/prevention & control , Tetracycline/administration & dosage , Administration, Topical , Aged , Aged, 80 and over , Female , Gels , Humans , Male , Middle Aged , Mouth Neoplasms/pathology , Neoplasm Staging , Surgical Wound Infection/microbiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL